Publications by authors named "D Watson-Jones"
Background: Conflict is known to impact maternal and neonatal health in Eastern Democratic Republic of the Congo (DRC), an area of longstanding insecurity. We conducted a systematic review on pregnancy and neonatal outcomes in this region to provide a comprehensive overview of maternal and neonatal outcomes over a 20-year period.
Methods: We systematically searched databases, such as Medline, EMBASE, Global Health, ClinicalTrials.
Background: Research in children is essential for them to benefit from the outcomes of research but involvement must be weighed against potential harms. In many countries and circumstances, medical research legally requires parental consent until the age of 18 years, with poorly defined recommendations for assent prior to this. However, there is little research exploring how these decisions are made by families and the ethical implications of this.
View Article and Find Full Text PDFEvaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.
Emerg Microbes Infect
December 2025
rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination.
View Article and Find Full Text PDFHuman papillomavirus (HPV) vaccines received regulatory approval and were recommended for use in young girls nearly 2 decades ago. Uptake is mostly high in resource-rich settings. In resource-limited settings, where the burden of cervical cancer is disproportionately high, access to and uptake of HPV vaccines are nowhere near satisfactory, despite evidence that HPV vaccination is highly cost-effective and a significant value-for-money investment.
View Article and Find Full Text PDFArticle Synopsis
- The study examined HPV infection prevalence among heterosexual men in Ibadan, Nigeria, highlighting a lack of existing data on this demographic compared to women.
- Results showed a 40.5% infection rate in penile sites, with lower rates in anal (9.7%) and oral (7.8%) sites; high-risk HPV types were more common in penile infections.
- The findings indicate that older men (25+) have higher odds of penile HPV, and there is a notable connection between penile and anal infections, emphasizing the need for further research on HPV's role in men's sexual health and transmission.